Science

NBRC scientists pave the way for a better understanding of Autism

Sunderarajan Padmanabhan New Delhi | Updated on February 03, 2020 Published on February 03, 2020

Autism or Autism spectrum disorder (ASD) is a neuro-developmental disorder where brain development goes awry, while Intellectual Disability (ID) is another neurodevelopmental disorder in which the patient displays low intelligence quotient (IQ) with decreased ability to learn, reason, make decisions and solve problems.

Both ASD and ID pose a substantial socio-economic burden on a global scale. However, there is no human-based models to study them. Consequently, there is a lack of knowledge of their pathophysiology, which is essential to design treatment strategies.

Researchers at the National Brain Research Centre at Manesar, Gurugram, have now filled the gap. They have developed a human-based model that could help study how the brain develops, particularly about neurons and what goes awry during brain development.

MicroRNAs (miRNAs) are small Ribonucleic Acid molecules. They are present inside every cell, from plants to humans. They regulate the expression of genes and thus control protein expression in cells. They are expressed in great numbers in a developing nervous system. Among other things, they play an essential role in determining the fate of stem cells, which are present in everyone’s brain and popularly known as human neural stem cells. However, scientists have not been able to figure out the exact manner by which they affect the stem cells.

The scientists at NBRC have used their new model to investigate the role of miRNA-137, a brain enriched miRNA, in determining the fate of human-induced pluripotent stem cells (iPSCs)-derived neural stem cells (hiNSCs). The iPSC derived NSCs are considered as ideal models to study neurodevelopmental disorders because one can derive iPSCs from patient’s blood, and it is possible to induce NSCs from them. They chose to research miRNA-137 since it is downregulated in ASD and ID.

Leader of the study team, Dr. Yogita K. Adlakha said, ”Our study demonstrated the crucial roles of miRNA-137 in determining the fate of human neural stem cells, with an elaboration of underlying molecular mechanism. It provides the first evidence that miRNA-137 inhibits proliferation of human neural stem cells while enhancing their differentiation towards neurons. The mitochondria are the powerhouse of a cell. During the study, we observed that miRNA-137 accelerates not only mitochondrial biogenesis, but also induces mitochondrial fusion and fission events. This resulted in increased mitochondrial content which is necessary for the newly born neurons. We propose that neural stem cell differentiation induced by miRNA-137 may facilitate the design of treatments for ageing-associated neurodegenerative diseases and ASD and ID”.

The researchers have submitted a report on their work to the international peer-reviewed journal “Stem Cells”, and it has been accepted for publication. The team included Asha S. Channakkar, Tanya Singh, Bijay Pattnaik, Kamika Gupta, and Pankaj Seth besides Yogita K. Adlakha.

Twitter handle: @ndpsr

(India Science Wire)

Published on February 03, 2020
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.